A Survey to Evaluate Diabetes Management, Control, Chronic Complications, Psychosocial Aspects of Children With Type 1 Diabetes

Diabcare Paediatric - A Survey-study on Diabetes Management, Complications and Psychosocial Aspects of Type 1 Childhood Diabetics

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01435642

Acronym

Diabcare

Enrollment

349

Registered

2011-09-16

Start date

2011-09-30

Completion date

2012-12-31

Last updated

2017-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Diabetes Mellitus, Type 1

Brief summary

This study is conducted in Africa. The aim of this non-interventional study is to evaluate the current status of diabetes management, complications and psychosocial aspects for children with type 1 diabetes in Algeria.

Interventions

OTHERNo treatment given

Subject will fill out a questionnaire when entering the non-interventional study

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

No minimum to 18 Years

Healthy volunteers

Inclusion criteria

* Informed consent obtained from the patient and his legal representative before any study-related activities (Study-related activities are any procedure related to recording of data according to the protocol) * Type 1 diabetes * Time since diabetes diagnosed at least 5 years * Followed for diabetes at consultation for at least 12 months

Exclusion criteria

* Patient previously included in this study * Secondary diabetes * Pregnant patient * Patient consulting for an emergency

Design outcomes

Primary

Measure	Time frame
Mean HbA1c (glycosylated haemoglobin)	At the first visit (only one study visit) after 12 month of follow up

Secondary

Measure	Time frame
Mean duration of insulin therapy	At the first visit (only one study visit) after 12 month of follow up
Mean number of insulin injections/day	At the first visit (only one study visit) after 12 month of follow up
Mean insulin units per day	At the first visit (only one study visit) after 12 month of follow up
Percentage of patients on insulin therapy	At the first visit (only one study visit) after 12 month of follow up
Percentage of patients having complications (ophthalmological, peripheral, renal and others)	At the first visit (only one study visit) after 12 month of follow up
To quantify quality of life	At the first visit (only one study visit) after 12 month of follow up
Percentage of patients on OAD or other treatments	At the first visit (only one study visit) after 12 month of follow up

Countries

Algeria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026